FindTrial
Sign In

Artificial Intelligence based assessment for cervix cancer: A retrospective study

Evaluation of Artificial Intelligence based assessment of Smart Scope�® images for single visit cervix cancer screening in low resource setting: A retrospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/09/045943
Enrollment
1500
Registered
2022-09-27
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Periwinkle Technologies Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Woman underwent cervical screening using the Smart Scope device. 2. Aged 25ââ?¬â??65 years 3. Non-Pregnant 4. No history of prior treatment for cancer of the cervix 5. No history of hysterectomy 6. Healthy enough to undergo pelvic examination

Exclusion criteria

Exclusion criteria: 1. Women not screened using Smart Scope

Design outcomes

Primary

MeasureTime frame
Non-inferiority evaluation of Artificial Intelligence based assessment with expertââ?¬â?¢s assessment of Smart ScopeÃ?® cervix images (AI Vs expert)Timepoint: around 12 months after CTRI registration—

Secondary

MeasureTime frame
Non-inferiority evaluation of AI based assessment of cervix using Smart ScopeÃ?® with histopathology assessment wherever available (AI Vs Histopath)Timepoint: At the end of 12th Month—

Countries

India

Contacts

Public ContactDr Manju Talathi

Bharati Vidyapeeth Medical College Pune

manjutalathi@yahoo.in91-9822884366

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026